Dopamine and Glutamate in Psychiatric Disorders

Continous rigorous research in basic neurosciences and in clinical studies has enormously increased our knowledge of the neurobiological basis of mental functions and of the neuronal dysfunctions underlying such diseases as schizophrenia, depression, attention deficit disorder, and Parkinson's...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Schmidt, Werner J. (Επιμελητής έκδοσης), Reith, Maarten E. A. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Totowa, NJ : Humana Press, 2005.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Dopamine
  • Dopamine Receptors
  • Dopamine Receptor Alternative Splicing
  • Glutamate
  • Glutamatergic Pathways
  • Glutamate Receptors
  • Metabotropic Glutamate Receptors
  • Schizophrenia
  • Dopamine and Schizophrenia
  • Glutamate and Schizophrenia and the N-Methyl-d-Aspartate Receptor Hypofunction Hypothesis
  • Role of Glycine in Schizophrenia
  • Depression
  • Dopamine and Depression
  • Glutamate and Depression
  • Stress and Aggression
  • Dopamine, Glutamate, and Aggression
  • Anxiety
  • Glutamatergic Systems and Anxiety
  • Attention Deficit Hyperactivity Disorder
  • Dopamine and Glutamate in Attention Deficit Hyperactivity Disorder
  • Addiction
  • Dopamine-Glutamate Interactions in Reward-Related Incentive Learning
  • Sensitization and Relapse
  • Glutamatergic Neurotransmission in Sensitization
  • Glutamatergic Mechanisms of Drug Relapse
  • Neurodegeneration
  • Dopamine and Neurodegeneration
  • Glutamate and Neurodegeneration
  • Parkinson’s Disease
  • Presymptomatic and Symptomatic Stages of Intracerebral Inclusion Body Pathology in Idiopathic Parkinson’s Disease
  • Dopamine and Glutamate in Parkinson’s Disease
  • Dopamine and Glutamate in Motor and Cognitive Symptoms of Parkinson’s Disease
  • Huntington’s Disease
  • Dopamine and Glutamate in Huntington’s Disease
  • Dementias
  • Dopaminergic and Glutamatergic Systems in Alzheimer’s Disease.